Session 14:
GONADOTROPIN-RELEASING HORMONE (GnRH) RECEPTOR BLOCKADE:
THE NEW APPROACH TO PROSTATE CANCER MANAGEMENT
An unrestricted educational grant by Ferring Pharmaceuticals

---